19355-10-3

Basic information

• Product Name: 1-benzyl-4-methyl-1,4-dihydronicotinamide
• CAS NO: 19355-10-3
• Molecular Weight: 228.294
• Mol File: 19355-10-3.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 1-benzyl-4-methyl-1,4-dihydronicotinamide(CAS DataBase Reference)
• NIST Chemistry Reference: 1-benzyl-4-methyl-1,4-dihydronicotinamide(19355-10-3)
• EPA Substance Registry System: 1-benzyl-4-methyl-1,4-dihydronicotinamide(19355-10-3)

Safety Data

• Hazardous Substances Data: 19355-10-3(Hazardous Substances Data)

Upstream product

• 16183-83-8 1-benzyl-3-carbamoylpyridinium ion 
• 952-92-1 1-Benzyl-1,4-dihydronicotinamide 
• 19355-05-6 1-benzyl-4-methyl-3-carbamoylpyridinium 
• 15519-25-2 3-(aminocarbonyl)-1-(phenylmethyl)pyridinium perchlorate 
• 22109-42-8 1-benzyl-3-carbamoyl-4-methylpyridinium bromide 
• 7250-52-4 4-methyl-3-pyridinecarboxamide 
• 100-44-7 benzyl chloride 
• 156030-71-6 [ruthenium(II)(2,2′:6′,2″-terpyridine)(2,2′-bipyridine)](1+) 

Downstream Products

• 4217-54-3 9,10-dihydro-10-methylacridine 
• 19234-05-0 9-(4'-methoxyphenyl)-9H-xanthene 
• 952-92-1 1-Benzyl-1,4-dihydronicotinamide 

Relevant articles and documents

Hydride Reduction of NAD(P)+ Model Compounds with a Ru(II)-Hydrido Complex

In order to better understand the regioselective hydride transfer of metal hydrido complexes to NAD(P)+ model compounds, reactions of [Ru(tpy)(bpy)H]+ (Ru-H: tpy = 2,2′:6″,2″-terpyridine, bpy = 2,2′-bipyridine) with various substitue

Thermodynamic characteristics of NADH/NAD+ analogues in acetonitrile: 2-methyl, 4-methyl and 2,4-dimethyl 1-benzyl-dihydronicotinamides and the corresponding pyridinium species

Procedures were elaborated for the syntheses of the title compounds. The thermodynamic changes brought about by each methyl substitution were then determined quantitatively. In acetonitrile, the respective one-electron oxidation and one-electron reduction

Reductive Methylation of NAD+ Analogues by a trans-Dimethylcobalt(III) Complex

Various NAD+ analogues are readily reduced by a trans-dimethylcobalt(III) complex to yield the corresponding methylated NADH analogues, while cis-dialkyl- or monoalkylcobalt(III) complexes cannot reduce the NAD+ analogues at all.